Back

Brain natriuretic peptide and left atrial volume predict the reduced flow velocity of left atrial appendage during sinus rhythm in patients with atrial fibrillation

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Epidemiology of atrial fibrillation Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Eiji Fukuhara

Hyogo College of Medicine, Nishinomiya (Japan)

19 More presentations in this session

Presentation thumbnail
Impact of atrial fibrillation detected by implantable cardioverter-defibrillators on future stroke events in patients with heart failure
Doctor M. Nakano (Chiba, JP)
Abstract
Presentation thumbnail
Improvement in ejection fraction predicts heart failure after catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction : from the KPAF registry
Doctor H. Fujimoto (Nara, JP)
Abstract Slides
Presentation thumbnail
Association of left atrial fibrosis extent with left ventricular geometric remodeling and diastolic dysfunction in patients with paroxysmal atrial fibrillation
Doctor T. Gizatulina (Tyumen, RU)
Abstract Slides
Presentation thumbnail
Catheter ablation outcome and heart failure hospitalization in atrial fibrillation patients with preserved left ventricular ejection fraction: insights from the Kansai plus atrial fibrillation (KPAF)
Doctor N. Tanaka (Osaka, JP)
Abstract Slides
Presentation thumbnail
Atrial fibrillation in arrhythmogenic right ventricular cardiomyopathy and its association with left atrial volume index
Doctor M. Baturova (Lund, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 6 - Epidemiology of atrial fibrillation

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Presentation
Oral anticoagulation in subclinical atrial fibrillation: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources